The Emerging Tech Summit – Saudi Arabia 2023
RIYADH, Sep 7, 2023 – (ACN Newswire) – The Emerging Tech Summit (ETS) (www.emergingtechsummit.com) is…
Year: 2023
Rover Metals Announces Results of Expanded Phase 1 Surface Exploration Program at Its LGL Lithium Project, Nevada, USA
Vancouver, BC, Sep 7, 2023 – (ACN Newswire) – Rover Metals Corp. (TSXV:ROVR)(OTCQB:ROVMF)(FSE:4XO) (“Rover” or…
CLARA Analytics Raises $24M in Series C Funding, Accelerating AI Adoption for Insurance Claims
SANTA CLARA, Calif.–(BUSINESS WIRE)–#AI—CLARA Analytics (“CLARA”), a leading provider of artificial intelligence (AI) technology for…
Three Additional Free Board Placements Made by Competitive Telecoms Group So Far This Quarter
MAHOPAC, N.Y.–(BUSINESS WIRE)–Competitive Telecoms Group (CTG), one of the leading consulting and recruiting companies in…
SproutLoud and InnerView Announce Strategic Partnership to Focus on Brand-to-Local Marketing
SUNRISE, Fla. & PHILADELPHIA–(BUSINESS WIRE)–SproutLoud, a leader in distributed marketing technology, and InnerView Group, a…
Core Scientific Announces August 2023 Production and Operations Updates
Operated approximately 206,000 owned and colocated bitcoin miners Produced 965 self-mined bitcoin and an estimated…
Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
Investigational New Drug (IND) application submitted to U.S. Food and Drug Administration (FDA) for ELX-02…
Eloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
Investigational New Drug (IND) application submitted to U.S. Food and Drug Administration (FDA) for ELX-02…
Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Five upcoming scientific presentations will add to the body of evidence supporting the advancement of…
Lexicon Announces Series of Presentations Relating to LX9211, Its Investigational Drug for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
Five upcoming scientific presentations will add to the body of evidence supporting the advancement of…
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
Table 1 Table 1 Chart 1 Chart 1 Chart 2 Chart 2 Table 2 Table…
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
Table 1 Table 1 Chart 1 Chart 1 Chart 2 Chart 2 Table 2 Table…
Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Oncternal Therapeutics Announces its Prostate Cancer Scientific Advisory Board
SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
ESCRS presentations will feature clinical data on APX3330 in diabetic retinopathy; Nyxol® data in presbyopia,…
Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September
ESCRS presentations will feature clinical data on APX3330 in diabetic retinopathy; Nyxol® data in presbyopia,…
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023
CAMBRIDGE, Mass. and NESS ZIONA, Israel, Sept. 07, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023
CAMBRIDGE, Mass. and NESS ZIONA, Israel, Sept. 07, 2023 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE…
INmune Bio Inc. to Present at Baird Global Healthcare Conference and H.C Wainwright 25th Annual Global Investment Conference
Boca Raton, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) — INmune Bio (NASDAQ: INMB), a clinical-stage…
INmune Bio Inc. to Present at Baird Global Healthcare Conference and H.C Wainwright 25th Annual Global Investment Conference
Boca Raton, FL, Sept. 07, 2023 (GLOBE NEWSWIRE) — INmune Bio (NASDAQ: INMB), a clinical-stage…